Molnupiravir is a five-day course of pills to be taken within the first few days of COVID-19 symptoms appearing

Ahead of a U.S Food and Drug Administration advisory panel meeting, drugmaker Merck has revealed final analysis data from a Phase 3 trial testing its oral antiviral pill against COVID-19. The new data reveals the treatment is significantly less effective than early indications.

Continue Reading

Category: Health & Wellbeing, Lifestyle

Tags: , , ,